Warning: The magic method InvisibleReCaptcha\MchLib\Plugin\MchBasePublicPlugin::__wakeup() must have public visibility in /home/obgynjp/obgyn.jp/public_html/wp-content/plugins/invisible-recaptcha/includes/plugin/MchBasePublicPlugin.php on line 37
TC療法はTP療法に非劣性である-卵巣癌III期の術後補助化学療法 | ObGyn.jp

TC療法はTP療法に非劣性である-卵巣癌III期の術後補助化学療法

第3相臨床試験の結果

PubMed
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Pac...
https://pubmed.ncbi.nlm.nih.gov/37643542/
Purpose: In randomized trials the combination of cisplatin and paclitaxel was superior to cisplatin and cyclophosphamide in advanced-stage epithelial ovarian cancer. Although in nonrandomized trials, carboplatin and paclitaxel was a less toxic and highly active combinat …

優越性試験、非劣性試験、同等性試験の読み方は、拙著『婦人科がんの分子病理学と治療レジメン』で図解して説明しています。